{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:44:23Z","timestamp":1760784263455},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.spen.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T15:00:38Z","timestamp":1491058838000},"page":"46-49","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Elevated Creatine Kinase in a 6-Year-Old Boy"],"prefix":"10.1016","volume":"26","author":[{"given":"Eunice K.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Kornberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.spen.2017.03.003_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3949\/ccjm.83a.14120","article-title":"Approach to asymptomatic creatine kinase elevation","volume":"83","author":"Moghadam-Kia","year":"2016","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"10.1016\/j.spen.2017.03.003_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/mus.21258","article-title":"Effect of newly proposed CK reference limits on neuromuscular diagnosis","volume":"39","author":"Nardin","year":"2009","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.spen.2017.03.003_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.spen.2017.03.003_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/archdischild-2014-307663","article-title":"A diagnostic approach to recurrent myalgia and rhabdomyolysis in children","volume":"100","author":"Chan","year":"2015","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.spen.2017.03.003_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/mus.23755","article-title":"Asymptomatic\/pauci-symptomatic creatine kinase elevations (hyperckemia)","volume":"47","author":"Silvestri","year":"2013","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.spen.2017.03.003_bib6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.wnl.0000216144.69630.6e","article-title":"Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia","volume":"66","author":"Fernandez","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.03.003_bib7","unstructured":"The National Organization for Rare Disorders. The physician\u2019s guide to Pompe disease. 2013. Available at: http:\/\/www.mda.org.nz\/media\/2529\/NORD_Physician_Guides_pompe_disease.pdf"},{"issue":"3","key":"10.1016\/j.spen.2017.03.003_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"Consensus treatment recommendations for late-onset Pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.spen.2017.03.003_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12883-015-0412-3","article-title":"Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group","volume":"15","author":"Al Jasmi","year":"2015","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.spen.2017.03.003_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ncl.2014.04.010","article-title":"Pompe disease: Literature review and case series","volume":"32","author":"Dasouki","year":"2014","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.spen.2017.03.003_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nmd.2008.11.007","article-title":"Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease","volume":"19","author":"van der Beek","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2017.03.003_bib12","article-title":"Late-Onset Pompe Disease","author":"Henderson","year":"2016","journal-title":"Res Rev"},{"issue":"5","key":"10.1016\/j.spen.2017.03.003_bib13","first-page":"506","article-title":"Late-onset Pompe\u2019s disease","volume":"32","author":"Teener","year":"2012","journal-title":"Semin Neurol"},{"issue":"5","key":"10.1016\/j.spen.2017.03.003_bib14","first-page":"267","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Eur J Neurol Genet Med"},{"issue":"8","key":"10.1016\/j.spen.2017.03.003_bib15","first-page":"497","article-title":"Clinical guidelines for late-onset Pompe disease","volume":"54","author":"Barba-Romero","year":"2012","journal-title":"Rev Neurol"},{"key":"10.1016\/j.spen.2017.03.003_bib16","first-page":"1","article-title":"Juvenile-onset Pompe\u2019s disease","author":"Kornberg","year":"2017","journal-title":"Res Rev"},{"key":"10.1016\/j.spen.2017.03.003_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-016-0442-y","article-title":"Childhood Pompe disease: Clinical spectrum and genotype in 31 patients","volume":"11","author":"Van Capelle","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.spen.2017.03.003_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe\u2019s disease: A review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.spen.2017.03.003_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2007.09.006","article-title":"Methods for a prompt and reliable laboratory diagnosis of Pompe disease: Report from an international consensus meeting","volume":"93","author":"Winchester","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.spen.2017.03.003_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ymgme.2006.12.006","article-title":"Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots","volume":"90","author":"Kallwass","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"1-2","key":"10.1016\/j.spen.2017.03.003_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cccn.2004.04.009","article-title":"Glycogen storage disease type II: Enzymatic screening in dried blood spots on filter paper","volume":"347","author":"Chamoles","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.spen.2017.03.003_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/mus.24620","article-title":"Electromyographic findings in 37 patients with adult-onset acid maltase deficiency","volume":"51","author":"Kassardjian","year":"2015","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.spen.2017.03.003_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880160614","article-title":"Adult acid maltase deficiency","volume":"16","author":"Barohn","year":"1993","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.spen.2017.03.003_bib24","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","article-title":"Respiratory insufficiency and limb muscle weakness in adults with Pompe\u2019s disease","volume":"26","author":"Pellegrini","year":"2005","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.spen.2017.03.003_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","article-title":"Pompe disease: A neuromuscular disease with respiratory muscle involvement","volume":"103","author":"Mellies","year":"2009","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.spen.2017.03.003_bib26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1183\/09031936.05.00112005","article-title":"Monitoring of pulmonary function in Pompe disease: A muscle disease with new therapeutic perspectives","volume":"26","author":"van der Ploeg","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.spen.2017.03.003_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-6-34","article-title":"Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy","volume":"6","author":"G\u00fcng\u00f6r","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2017.03.003_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1172-8-49","article-title":"Impact of enzyme replacement therapy on survival in adults with Pompe disease: Results from a prospective international observational study","volume":"8","author":"G\u00fcng\u00f6r","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.spen.2017.03.003_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.spen.2017.03.003_bib30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.spen.2017.03.003_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00431-013-2258-2","article-title":"Enzyme replacement therapy in juvenile glycogenosis type II: A longitudinal study","volume":"173","author":"Deroma","year":"2014","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.spen.2017.03.003_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience","volume":"160C","author":"Bali","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"10.1016\/j.spen.2017.03.003_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bone.2010.06.021","article-title":"Low bone mass in Pompe disease: Muscular strength as a predictor of bone mineral density","volume":"47","author":"van den Berg","year":"2010","journal-title":"Bone"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117300165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117300165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T21:34:53Z","timestamp":1544564093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909117300165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":33,"alternative-id":["S1071909117300165"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2017.03.003","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated Creatine Kinase in a 6-Year-Old Boy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}